Latest Articles
The weaponization of predictive data analytics, red flags, and the chronic pain gender gap has become a radioactive crisis in U.S. health care - Kevin MD
The weaponization of predictive data analytics, red flags, and the chronic pain gender gap has become a radioactive crisis in U.S. health care Kevin MD
Published: Feb. 5, 2025, 8:06 p.m.
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? - Medpage Today
ASCO Reading Room | Is the End of Systemic Chemotherapy Near for Advanced Endometrial Cancer? Medpage Today
Published: Feb. 5, 2025, 7:31 p.m.
Amy Schumer Experienced This 'Scary' Complication During Her Pregnancy With Son Gene - Women's Health
Amy Schumer Experienced This 'Scary' Complication During Her Pregnancy With Son Gene Women's Health
Published: Feb. 5, 2025, 6:55 p.m.
New evidence on the association between endometriosis and traumatic and stressful experiences - Universitat de Barcelona
New evidence on the association between endometriosis and traumatic and stressful experiences Universitat de Barcelona
Published: Feb. 5, 2025, 6:50 p.m.
Women with endometriosis earn less, research shows - MSN
Women with endometriosis earn less, research shows MSN
Published: Feb. 5, 2025, 5:59 p.m.
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer - Medpage Today
Christian Marth on a First-Line Chemotherapy-Free Option for Advanced Endometrial Cancer Medpage Today
Published: Feb. 5, 2025, 5:54 p.m.
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial - Medpage Today
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial Medpage Today
Published: Feb. 5, 2025, 5:54 p.m.
New evidence strengthens link between endometriosis and traumatic experiences - Medical Xpress
New evidence strengthens link between endometriosis and traumatic experiences Medical Xpress
Published: Feb. 5, 2025, 5:54 p.m.
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer - OncLive
FDA Grants Breakthrough Device Designation to ACR-368 OncoSignature Assay for Endometrial Cancer OncLive
Published: Feb. 5, 2025, 5:17 p.m.
Women with endometriosis earn less, research shows - AOL
Women with endometriosis earn less, research shows AOL
Published: Feb. 5, 2025, 5:17 p.m.
Link copied to clipboard!